FDA asks DNDN for interm result

Discussion in 'Stocks' started by codedeep007, May 9, 2007.

  1. FDA asks DNDN to unblind IMPACT now, absolutely logical

    The IMPACT started 4 years ago, should have at least additional 100-200 patients.

    DNDN can use this extra 100-200 patient data per FDA to support its claim
  2. empee


    i think DNDN opens at 5.80 tommorow.
  3. Congrats to May put buyers who had the balls to make that move. I may buy this at $3. I'm stuck holding some other shit biotech's though like AVNR and ACUS specifically. F me!
  4. dont buy this ever...